|
HY-103332-10mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-100mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-25mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-5mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-103332-50mg
|
MedChemexpress LLC
|
N-Arachidonylglycine [CAS 179113-91-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-124754-10mg
|
MedChemexpress LLC
|
Navacaprant [CAS 2244614-14-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-124754-5mg
|
MedChemexpress LLC
|
Navacaprant [CAS 2244614-14-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-124754-50mg
|
MedChemexpress LLC
|
Navacaprant [CAS 2244614-14-8]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-124754-1mL
|
MedChemexpress LLC
|
Navacaprant [CAS 2244614-14-8] (10mM in DMSO)
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-10405-10mg
|
MedChemexpress LLC
|
Pamapimod [CAS 449811-01-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-10405-25mg
|
MedChemexpress LLC
|
Pamapimod [CAS 449811-01-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-10405-5mg
|
MedChemexpress LLC
|
Pamapimod [CAS 449811-01-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-10405-50mg
|
MedChemexpress LLC
|
Pamapimod [CAS 449811-01-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-10405-1mL
|
MedChemexpress LLC
|
Pamapimod [CAS 449811-01-2] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-16749A-1g
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-16749A-10g
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-16749A-10mg
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-16749A-2g
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-16749A-20g
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-16749A-200mg
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-16749A-5g
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-16749A-5mg
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-16749A-50mg
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-16749A-500mg
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-16749A-1mL
|
MedChemexpress LLC
|
Pexidartinib (hydrochloride) [CAS 2040295-03-0] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
